Every material Form 8-K Eastman Chemical filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Eastman reported third quarter 2024 sales of $2.46 billion, up 9% from $2.27 billion a year earlier, with GAAP diluted EPS of $1.53 versus $1.49 and adjusted diluted EPS of $2.26 versus $1.47. The company kept the midpoint of its full-year adjusted EPS guidance unchanged and expects 2024 EPS of $7.50 to $7.70, while saying the Kingsport methanolysis facility has taken longer than expected to reach consistent production rates.
Third quarter sales were $2,464 million versus $2,267 million, driven by an 8% increase in sales volume/mix.
GAAP diluted EPS was $1.53 versus $1.49; adjusted diluted EPS was $2.26 versus $1.47.
The company expects 2024 EPS of $7.50 to $7.70 and cash from operations of approximately $1.3 billion, with the adjusted EPS guidance midpoint unchanged.
Eastman made an investment decision to build a second methanolysis facility in Longview, Texas, and returned $195 million to shareholders in the quarter, including $100 million of share repurchases.
Eastman Chemical Company issued $500 million of 5.000% notes maturing August 1, 2029, in a public offering that closed on August 1, 2024. The company expects net proceeds of about $494.4 million and plans to use part of them for a concurrent tender offer for up to $250 million of its 3.800% notes due 2025, with any remainder for general corporate purposes.
$500 million aggregate principal of 5.000% notes due August 1, 2029, issued August 1, 2024
Expected net proceeds of approximately $494.4 million after underwriting discounts and estimated expenses
Concurrent tender offer for up to $250 million of 3.800% notes due 2025; interest on new notes paid February 1 and August 1, starting February 1, 2025
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Eastman Chemical filing is on SEC EDGAR ↗. 8-K briefs of other companies →